From a soil isolate, Pseudomonas strain C18, we cloned and sequenced a 9.8-kb DNA fragment that encodes dibenzothiophene-degrading enzymes. Nine open reading frames were identified and designated doxABDEF-GHIJ. Collectively, we refer to these genes as the DOX pathway. At the nucleotide level, doxABD are identical to the ndoABC genes that encode naphthalene dioxygenase of Pseudomonas putida. The DoxG protein is 97% identical to NahC (1,2-dihydroxynaphthalene dioxygenase) of P. putida. DoxE has 37% identity with cis-toluene dihydrodiol dehydrogenase. DoxF is similar to the aldehyde dehydrogenases of many organisms. The predicted DoxHIJ proteins have no obvious sequence similarities to known proteins. Gas chromatography with a flame ionization detector and mass spectroscopy confirmed that the DOX proteins convert naphthalene to salicylate and convert phenanthrene to 1-hydroxy-2-naphthoic acid. doxI mutants convert naphthalene to trans-ohydroxybenzylidenepyruvate, indicating that the DoxI protein is similar to NahE (trans-o-hydroxybenzylidenepyruvate hydratase-aldolase). Comparison of the DOX sequence with restriction maps of cloned naphthalene catabolic pathway (NAH) genes revealed many conserved restriction sites. The DOX gene arrangement is identical to that proposed for NAH, except that the NAH equivalent of doxH has not been recognized. DoxH may be involved in the conversion of 2-hydroxy-4-(2'-oxo-3,5-cyclohexadienyl)-buta-2,4-dienoate to cis-ohydroxybenzylidenepyruvate. doxJ encodes an enzyme similar to NahD (isomerase). Our findings indicate that a single genetic pathway controls the metabolism of dibenzothiophene, naphthalene, and phenanthrene in strain C18 and that the DOX sequence encodes a complete upper naphthalene catabolic pathway similar to NAH.
The biochemical pathway for the metabolism of dibenzothiophene (DBT) in Pseudomonas strains has been described by Kodama et al. (32) and results in the degradation of one of the aromatic rings of DBT to yield 3-hydroxy-2-formyl-benzothiophene. This pathway for DBT metabolism has biochemical similarities to the oxidative metabolic pathways of naphthalene (10) , phenanthrene (13) , and anthracene (13) . Some DBT- degradative genes have been shown to have DNA homology with naphthalene-degradative plasmids (16) , but the sequence of the gene(s) encoding DBT metabolism has not been previously determined.
Soil isolate C18 (a Pseudomonas sp.) was identified as a DBT-metabolizing organism on the basis of its ability to produce a UV-fluorescent compound from DBT (34) . We isolated a 9.8-kb DNA fragment from C18 that conferred the DBT-metabolizing phenotype on Pseudomonas putida and Escherichia coli. Since this DNA was identified and cloned by its ability to metabolize DBT, we designated this group of genes DOX (for DBT oxidation), but the nucleotide sequence revealed that several of the dox open reading frames (ORFs) have sequence identities with genes for enzymes known to degrade other aromatic compounds. These include the naphthalene, biphenyl, benzene, and toluene dioxygenases of P. putida. Sequence similarities between the dox ORFs and Pseudomonas genes involved in naphthalene catabolism (ndo-ABC and nahC) suggested that DOX proteins would metabolize naphthalene. Using gas chromatography with a flame DBT AND NAPHTHALENE METABOLISM GENES 6891 A. M. Chakrabarty (University of Illinois) (7) , carries the lacIt' repressor gene and was used to place the E. coli lac repressor into P. putida KT2440. pBluescript (Stratagene) was used to generate nested deletion clones for DNA sequencing.
Cosmid library construction. High-molecular-weight DNA was isolated from C18 by the method of Consevage et al. (4) . The DNA was partially digested with Sau3AI, and -20-kb fragments were isolated from a sodium chloride gradient (17) . These fragments were ligated into the BamHI site of pLAFR5. In vitro packaging was performed by using Gigapack Plus (Stratagene). Packaged cosmids were transduced into E. coli S17-1 (8) .
Bacterial matings. The C18 cosmid library (in E. coli S17-1) was introduced into P. putida KT2440 via conjugal mating. S17-1 colonies containing the C18 cosmid library were recovered from LB-tetracycline plates, resuspended in 7 ml of fresh LB-tetracycline, and shaken at 37°C for 2 h. These cells (0.5 ml at 5 x 109/ml) were mixed with log-phase P. putida KT2440 (0.5 ml at 5 x 109/ml), centrifuged briefly (15 s) in a microcentrifuge, resuspended in 50 [L of LB, and incubated at 30(C for 4 h. Cells were plated on PMS-ampicillin-tetracycline and incubated at 30°C. Since E. coli plated at high densities can survive on PMS media, ampicillin was included to select against E. coli. KT2440 is ampicillin resistant. Individual colonies were isolated, purified, and tested for a DBT-positive phenotype by the DBT plate assay.
DBT plate assay. A plate assay for the identification of bacteria capable of modifying DBT was originally described by Kiyohara et al. (31) and modified by S. Krawiec (34) . We further modified the assay as follows. Cells were streaked in small patches (0.5 cm) onto PMS-1% agarose (Bethesda Research Laboratories) plates and grown at 30°C for a minimum of 36 h. By using a chromatographic sprayer, plates were lightly sprayed with 0.1% DBT in ethyl ether. Plates were incubated at 30°C, and fluorescent products around the colonies were detected by viewing them under short-wavelength (254-nm) UV light. Fluorescence was visible as early as 20 min after spraying. Colored products that are visible in white light were also formed, but this color typically took 2 to 18 h to develop fully.
The plate assay was also used to test for metabolism of phenanthrene. With this compound, UV-fluorescent products were readily observed but no brightly colored products were detected. After several days of incubation, cells capable of metabolizing DBT or phenanthrene would also form a clear zone around the colonies, indicating the DBT or phenanthrene had been degraded.
Plasmid DNA isolation. Cosmid DNA (pLAFR5) was isolated as described by Ish-Horowicz and Burke (28) . Plasmid DNA (pDSK519 and pBluescript) was isolated by the boiling method of Holmes and Quigley (25) .
DNA sequencing, sequence analysis, and construction of dox mutants. Deletion clones for DNA sequencing were constructed in pBluescript by using exonuclease III (New England BioLabs) and the method of Henikoff (24) . The DNA nucleotide sequences of both strands were determined by the dideoxy-chain termination method of Sanger et al. (41) Nucleotide sequence accession number. The DOX nucleotide sequence has been submitted to GenBank and assigned accession number M60405.
RESULTS
Isolation of DBT-positive cosmids. High-molecular-weight DNA from C18 was partially digested with Sau3AI and inserted into the BamHI site of pLAFR5. This cosmid library was transduced into E. coli S17-1 and mated into P. putida KT2440. Transformed colonies were maintained on LB-tetracycline plates. Since tetracycline is fluorescent under UV light, clones were transferred to PMS-agarose plates in order to screen for the production of UV-fluorescent products in the DBT plate assay. Duplicate plating also allowed us to avoid cloning UV-induced mutations. Cosmids could be recovered from colonies grown for several days in the absence of tetracycline (data not shown).
In the DBT plate assay, 23 transformed colonies were distinctively colored in visible light. Of these, 20 were orange and 3 were dark brown. Untransformed KT2440 and KT2440 transformed with pLAFR5 were not colored when sprayed with DBT. All orange colonies were UV fluorescent in the presence of DBT, but the brown colonies were not fluorescent in the DBT assay. The 23 positive clones were designated pSADC18-1 to -23. Cosmid DNA was purified from each clone and used to transform E. coli SI 7-1. Cosmids were mated into naive KT2440 and retested to confirm that the cosmids carried DNA that conferred the DBT-positive phenotype.
Subcloning the DBT-modifying genes. Cosmid DNAs from 11 unique pSADC18 clones were digested with EcoRI and separated on 1% agarose gels. These fragments were transferred to a Biotrans nylon membrane and hybridized with 32P-labeled C18 DNA from pSADC18-9. All the clones shared at least some portion of an 18-kb EcoRI fragment (Fig. 1 ). pSADC18-3 contained 9.8 kb of this 18-kb fragment and retained DBT-dependent fluorescence. Clone pSADC18-12, which contained 6.5 kb of the 18-kb fragment, produced a brown nonfluorescent product in the DBT plate assay.
The 9.8-kb EcoRI fragment from pSADC18-3 was subcloned into pDSK519 in both orientations. When transformed into KT2440, only subclone pSAD3EB-3 was colored (orange) and fluorescent in the DBT assay. Clones containing the 9.8-kb fragment in the opposite orientation were not. This suggested that the endogenous C18 promoter had been removed and that the genes were being expressed from the lac promoter in the J. BACTERIOL. vector. Since P. putida does not contain a lac repressor, the genes encoded by pSAD3EB-3 were expressed constitutively in KT2440. KT2440 containing pSAD3EB-3 was transformed with pVDtac24, which encodes the lac repressor. The resulting strain was negative in the DBT assay unless IPTG (isopropyl-3-D-thiogalactopyranoside) (5 mM) was added to inactivate the lac repressor. This confirmed that the genes encoded by pSAD3EB-3 were being expressed from the lac promoter.
Not all the dox genes are expressed in E. coli. The pSADCI8 cosmid clones isolated in P. putida were transferred to E. coli CS109 and tested in the plate assay. All were orange or brown in the presence of DBT, but none were UV fluorescent, suggesting that only a subset of the DBT-degrading genes are expressed in E. coli. Subclone pSAD3EB-3 was transformed into E. coli XL1-Blue, and expression from the lac promoter was induced with IPTG (1 mM). When sprayed with DBT, these colonies were still color positive (orange) but were not UV fluorescent.
Presumptive indigo formation by dox clones. The production of indigo from indole is known to be a property of the naphthalene dioxygenase genes (11, 35) . P. putida KT2440 colonies containing any of the pSADC18 clones had no unusual color when grown on PMS or LB plates. This was also true forE. coli S17-1. However, E. coli CS109 transformed with the pSADC18 clones formed blue colonies on LB, but not on PMS, plates. This blue color formed in the absence of DBT. When the pSADC18 clones in E. coli CS109 were grown on PMS-thiamine (5 p.g/ml) without or with tryptophan (40 pLg/ml), the blue color formed only when tryptophan was present, indicating that the pSADC18 clones might be converting indole to indigo. All the pSADC18 clones exhibited a blue color in LB medium in E. coli CS109 and XL1-Blue, including those clones which were brown but not fluorescent in the presence of DBT. We do not know why indigo was not produced in E. coli S17-1 even though the strain was indole positive, indicating that S17-1 contained the enzyme tryptophanase. Tryptophanase transforms tryptophan to indole, the substrate from which naphthalene dioxygenase produces indigo (11, 35) . Indigo was not produced in KT2440, consistent with the absence of tryptophanase.
DOX genes are located on a plasmid in C18. Endogenous plasmids in C18 were separated from chromosomal DNA by hexagonal pulsed-field gel electrophoresis. Immobilization of whole cells in agarose blocks prior to cell disruption eliminated mechanical breakage of the chromosome and any large plasmids. Ethidium bromide staining revealed two major plasmids (325 and 75 kb), with a minor band at 150 kb (Fig. 2 ). Southern analysis using 32P-labeled C18 DNA from pSADC18-9 as the probe revealed that the DBT-modifying genes are located on the 75-kb plasmid. Faint hybridization to the 150-kb plasmid was also detected. This band may be a dimer of the 75-kb plasmid. No hybridization to either the 700-kb chromosomal DNA band or the 325-kb band was detected. Genomic blots hybridized under low-stringency conditions indicated that there was only one copy of the 9.8-kb DNA in the genome (data not shown).
DNA sequence analysis. One hundred thirty-seven individual clones generated by the exonuclease III deletion strategy were used to sequence both strands of the 9.8-kb fragment from pSAD3EB-3 ( Fig. 3) . Analysis of the DNA sequence revealed 10 ORFs. All started with methionine and were greater than 100 amino acids in length. We refer to nine of these (doxABDEFGHIJ) as the DOX genes (DBT oxidation), since they were identified and cloned by their ability to metabolize DBT. Possible ribosomal binding sites, on the basis of complementarity to the 3' end of 16S rRNA from Pseudo- A search of the Swiss-Prot protein data base identified a number of proteins with significant similarities to the predicted protein products of doxABDEFG (Table 1) . doxxABD are identical to the ndoABC genes that encode naphthalene dioxygenase in P. putida NCIB9816 (35) . DoxG is very similar to NahC (1,2-dihydroxynaphthalene dioxygenase) from P. putida (20) at both the nucleotide and predicted amino acid levels. DoxABDEG also have similarities to proteins known to be involved in the oxidative degradation of toluene (49), benzene (27) , and biphenyl (12) . doxF is similar to aldehyde dehydrogenases from rats (9, 14) , horses (29) , humans (3, 22, 23) , Aspergillus nidulans (40) , Pseudomonas oleovorans (33) , and E. coli (21) . No significant similarities were found for doxHIJ.
GC analysis shows that dox clones convert naphthalene to salicylate. GC-FID-MS data for the DBT metabolic intermediates produced by pSAD3EB-3 were difficult to interpret because of a lack of suitable standards. Since the nucleotide sequence analysis revealed sequence similaritics between DOX and the naphthalene catabolic pathway (NAH), we grew pSAD3EB-3 with naphthalene and analyzed supernatants for NAH metabolic intermediates. GC-FID-MS analysis revealed that DOX enabled P. putida KT2440 to convert naphthalene to salicylate.
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E--14 6896 DENOME ET AL. A similar analysis showed that phenanthrene was converted to 1-hydroxy-2-naphthoic acid. This indicated that the same DOX enzymes degraded DBT, naphthalene, and phenanthrene. We could not detect any production of salicylate from phenanthrene, indicating that DOX does not encode an enzyme that converts 1-hydroxy-2-naphthoic acid to 1,2-dihydroxynaphthalene, as in the pathway proposed by Evans et al. (13) .
Analysis of dox mutants. We constructed clones from pSAD3EB-3 that contained mutations in individual dox ORFs. Each mutant was evaluated by the DBT plate assay, and two phenotypes were observed. If the entire pathway was functional, a UV-fluorescent product was observed around the colony. Many of the mutants lost the ability to produce this fluorescent product. In addition, some of the mutant colonies were colored in the presence of DBT. The color produced depended on which ORF was mutated ( Table 2 ). The mutants were also evaluated for the ability to produce a blue color when grown on LB medium. The production of this blue color (presumably indigo) was tryptophan dependent and is known to be a property of the naphthalene dioxygenase genes (11, 35) .
These same mutants were grown in the presence of naphthalene and analyzed for the accumulation of naphthalene metabolic intermediates by GC-FID-MS. In all cases, the results were consistent with those of the DBT plate assay ( (38) . The sequence for nahA is not available.
(ii) doxB mutants. doxB mutants could not produce UVfluorescent products from DBT or naphthalene. doxB mutants could not produce indigo, indicating the dioxygenase was not functional. No intermediates of naphthalene metabolism were detectable by GC-MS. These results and the sequence similarities between DoxB and the dioxygenases of naphthalene (NdoB) (100%), benzene (34%), biphenyl (41%), and toluene (34%) lead us to conclude that doxB also encodes a component of the naphthalene dioxygenase complex. Neidle et al. have compared the relationships among many of these multicomponent oxygenases (38) , and doxA and doxB are new members of this group.
(iii) orfC mutants. We could not construct mutations in orfC without mutating doxB or doxD. We could not find any (38) .
(v) doxE mutants. doxE contains two possible translational start sites, the methionines at nt 2466 and 2514. When doxE was mutated at a position between these two methionines (at nt 2483), the clones continued to produce UV-fluorescent products from DBT and naphthalene. Salicylate was produced from naphthalene, although the amount produced was less than that observed with the nonmutated clone (87 versus 252 Rg). When doxE was mutated at a position after the second methionine (at nt 2839), the colonies were light brown in the presence of DBT. No UV-fluorescent products were produced from DBT or naphthalene. The ability to produce indigo was not lost, indicating that the naphthalene dioxygenase complex was not mutated. No salicylate was produced from naphthalene. These results suggest that translation from the second methionine is sufficient to produce a functional DoxE protein.
Sequence similarity searches found the predicted DoxE protein to be similar to cis-toluene dihydrodiol dehydrogenase (37%) and the P5 component of the benzene dioxygenase complex (40%). These proteins are a subset of a growing family of short-chain alcohol dehydrogenases (39) . The sequence for the naphthalene equivalent of this enzyme is not available. The sequence similarities and our experimental data led us to conclude that doxE encodes cis-naphthalene dihydrodiol dehydrogenase (nahB), but we were unable to identify the unstable naphthalene metabolic intermediate (cis-1,2-dihydroxy-1,2-dihydronaphthalene) that should have accumulated with a doxE mutant.
(vi) doxF mutants. The doxF mutants produced UV-fluorescent products from both DBT and naphthalene. Salicylate was identified as a product of naphthalene metabolism, and the mutants remained capable of producing indigo, indicating that doxF does not encode part of the naphthalene dioxygenase complex.
In the naphthalene operon, nahF encodes salicylaldehyde dehydrogenase, but the sequence is unavailable. Sequence searches indicated that DoxF is similar to the aldehyde dehydrogenases of many different organisms and may be the equivalent of NahF. The highly conserved amino acid sequence LELGGKSP is present in all sequenced aldehyde dehydrogenases, as well as in DoxF. In the human liver enzyme, the glutamate residue in this sequence is part of the enzyme's active site (1). Horn et al. discussed the significance of conserved amino acid residues in the activity of the aldehyde dehydrogenase superfamily (26) .
The naphthalene pathway of the doxF mutant was complete and produced salicylate. We were unable to detect accumulation of the expected intermediate, salicylaldehyde. There are several possible explanations for the unaffected phenotype of the doxF mutants. First, the mutation could be in frame, resulting in a functional protein. Second, doxF may be unnecessary in the pathway. This is unlikely since salicylaldehyde dehydrogenase has been identified as a component of the NAH pathway. Third, since both doxE and doxF encode dehydrogenases, it is possible that the DoxE protein can substitute for DoxF in the pathway, though the evidence suggests that the DoxF protein cannot substitute for DoxE. Finally, an aldehyde dehydrogenase encoded by a chromosomal gene may be substituting for DoxF.
(vii) doxE doxF mutants. The AdoxEF mutant behaved exactly like the doxE clone that was mutated after the second methionine (see above).
(viii) doxG mutants. doxG mutants produced a dark brown product in the presence of DBT, naphthalene, or phenanthrene. No UV-fluorescent products were formed from DBT or naphthalene. Although salicylate was not produced from naphthalene, we did detect an unidentified product. The doxG mutant could still produce indigo, indicating that the doxG product is not a part of the naphthalene dioxygenase complex.
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Sequence similarity searches revealed that DoxG is very similar to the NahC protein (1,2-dihydroxynaphthalene dioxygenase) (97%), 2,3-dihydroxybiphenyl dioxygenase (60%), and 3-methylcatechol-2,3-dioxygenase (35%). In fact, the predicted protein product of doxG differs from the NahC protein at only eight amino acids, indicating that doxG encodes 1,2-dihydroxynaphthalene dioxygenase. Although we could not identify the predicted naphthalene intermediate (1 ,2-dihydroxynaphthalene) that should result from the inactivation of 1,2-dihydroxynaphthalene dioxygenase, the doxG mutant did produce a dark brown product in the DBT plate assay. 1,2-Dihydroxynaphthalene is reported to be a colorless compound that readily oxidizes at pH 7.0 to form the quinone, which is brown (5). Our assays were normally performed at pH 6.8, and the brown products produced from the doxG mutant are probably quinones. Samples of commercially available 1,2-dihydroxynaphthalene (obtained from Aldrich) were also dark brown. Such a product has not been described for the DBT pathway, but considering the similarities of these compounds, it is very likely that a quinone is also formed from 1,2-dihydroxydibenzothiophene.
(ix) doxH mutants. AdoxH mutants produced a light yelloworange color in the presence of DBT, and UV-fluorescent products were formed from DBT and naphthalene. Naphthalene was metabolized to salicylate, and the AdoxH mutant could still produce indigo. We could not find any similarities between the DoxH sequence and other known protein sequences. Mutations in doxH do not appear to affect the pathway. Since the AdoxH mutation is a large deletion, it is unlikely that any functional DoxH protein is being produced. It appears that doxH is not essential for the pathway to function.
However, a AdoxH doxJ double mutant indicated otherwise (see "doxH doxJ mutants" below). There is no recognized NAH equivalent of doxH.
(x) doxI mutants. doxI mutants produced a dark orange product in the presence of DBT. No UV-fluorescent products were formed from DBT or naphthalene, and no salicylate could be detected. Instead, doxI mutants accumulated coumarin, dihydrocoumarin, and trans-o-hydroxybenzylidenepyruvate as naphthalene-metabolic intermediates. Coumarin is a deadend metabolic product that has been previously associated with the naphthalene catabolic pathway (5) . The doxI mutants were capable of producing indigo in LB medium, indicating that doxl does not encode naphthalene dioxygenase.
We could not find similarities between the DoxI sequence and any other known protein sequence. From the metabolism of naphthalene to trans-o-hydroxybenzylidenepyruvate, we can conclude that doxI encodes a protein similar to NahE (transo-hydroxybenzylidenepyruvate hydratase-aldolase). The sequence for nahE is unavailable.
(xi) doxJ mutants. Mutations in doxJ do not appear to affect the pathway. doxJ mutants produced a light yellow-orange color in the presence of DBT, and UV-fluorescent products were formed from DBT and naphthalene. Naphthalene was metabolized to salicylate, and the doxJ mutant could still produce indigo. We could not find any similarities between the DoxJ sequence and other known protein sequences. Although it appears that doxJ is not essential for the pathway to function, a AdoxH doxJ double mutant indicated otherwise (see "doxH doxJ mutants" below).
(xii) doxI doxJ mutants. Clones containing mutations in both doxI and doxJ behaved exactly the same as the doxI single mutant.
(xiii) doxH doxJ mutants. The AdoxH doxJ double mutants produced a light yellow-orange color in the presence of DBT and also produced UV-fluorescent products from DBT and naphthalene. The difference between the AdoxH doxJ double mutant and either the AdoxH or doxJ single mutant was that the UV-fluorescent product produced from naphthalene was not salicylate. This UV-fluorescent product was not identified. Coumarin (48) . Much of the biochemical analysis of the upper naphthalene pathway was derived by using the NAH7 catabolic plasmid, and the genes encoding this pathway are designated nah. The amino acid sequence of NahC is identical to that of DoxG at 294 of 302 amino acid positions. The ndo genes were cloned from P. putida NCIB9816 and were not derived from an NAH7 plasmid. The exact identities of doxABD to ndoABC indicate that they may be derived from the same catabolic plasmid group. The similarity of the dox, nah, and ndo sequences indicates that these catabolic plasmid groups are closely related. Using pulsed-field gel electrophoresis, we determined that in C18 the DOX genes reside on a 75-kb plasmid, which is very close to the size of the NAH7 plasmid (83 kb). Other sequences from NAH have not been published, so we cannot determine the extent of the sequence similarity between NAH and DOX.
The NAH pathway may include another gene. The genetic and biochemical pathways of the NAH operon have recently been revised by Eaton and Chapman (10) (Fig. 4 and 5) . It is interesting that the genetic order of the NAH genes is identical to the order of the DOX genes, with the exception of doxH.
Comparison of the DOX sequence and the NAH restriction map of Eaton and Chapman (10) indicated a high degree of sequence similarity between NAH and DOX (Fig. 5) . In fact, there is a very good correlation between the restriction sites of nahD and doxJ, which suggests that they may encode similar enzymes. Eaton and Chapman concluded that the nahD product is responsible for the isomerization of 2-hydroxychromene-2-carboxylate to trans-o-hydroxybenzylidenepyruvate, but they thought that this isomerization also occurred spontaneously. Although Since doxJ may cncodc the equivalent of the protein encoded by nahD, this suggests that the DoxH protein is involved either in the conversion of 2-hydroxy-4-(2'-oxo-3,5-cyclohexadienyl)-buta-2,4-dienoate to cis-o-hydroxybenzylidcnepyruvate or in the conversion of cis-o-hydroxybenzylidenepyruvate to 2-hydroxychromene-2-carboxylate (Fig. 4) . Our AdoxH doxJ mutant accumulated coumarin from naphthalene, but we did not detect the accumulation of cis-or trcanis-o-hydroxybenzylidenepyruvate, indicating that the pathway was blocked before these intermediates were formed. Coumarin may form spontaneously from any of the isomers of o-hydroxybenzylidenepyruvate (5) . This suggests that doxH may be involved in the conversion of 2-hydroxy-4-(2'-oxo-3,5-cyclohexadienyl)-buta-2,4-dienoate to cis-o-hydroxybenzylidenepyruvate. This conclusion is not supported by the observations of Eaton and Chapman (10) . They indicated that this conversion is attained spontaneously, and they could not detect any isomerasc activity encoded between nahC and nahE. Yen and Gunsalus (47) did detect isomerase activity encoded between nahC and nahE, and our results with the AloxHJ double mutants indicate that a second isomerase does exist. Hopefully, further invcstigations will sort out these facts.
The DOX and NAH equivalents. NAH. Using NAH as a guideline, we have used GC-FID-MS to establish enzymatic functions for many of the dox ORFs. Although we do not have direct enzymatic evidence for the function of each dox ORF, our assays and sequence comparisons enable us to suggest where each dox ORF may function in the naphthalene pathway. These assignments are indicated in Fig. 4 : doxABD comprise the C18 equivalent of naphthalene dioxygenase (= nahA); doxE encodes cis-naphthalene dihydrodiol dehydrogenase (= nahB); doxF encodes salicylaldehyde dehydrogenase (= nahF); doxG encodes 1,2-dihydroxynaphthalene dioxygenase (= nahC); doxH may encode an enzyme (no nah equivalent) responsible for the conversion of 2-hydroxy-4-(2'-oxo-3,5-cyclohexadienyl)-buta-2,4-dienoate to ciso-hydroxybenzylidenepyruvate; doxI encodes trans-o-hydroxybenzylidenepyruvate hydratase-aldolase (= nahE); and doxJ encodes an isomerase responsible for the conversion of 2-hydroxychromene-2-carboxylate to trans-o-hydroxybenzylidenepyruvate (= nahD). We have no evidence that orfC encodes a functional protein.
Is DOX a single operon? We have resisted referring to this set of ORFs as the DOX operon, since we have not done any Northern (RNA) analysis to confirm this. Nevertheless, the first six ORFs (doxABDEFG) appear to constitute a single operon that functions in both P. putida and E. coli. The largest interval between any of these ORFs is the 70 bp between doxA and doxB. The endogenous C18 promoter located 5' to doxA was probably deleted when the 9.8-kb DNA fragment was subcloned to produce pSAD3EB-3, because DBT was not metabolized by E. coli CS109 unless the cloned genes were in the correct orientation to place them under control of the E. coli lac promoter supplied by the vector.
There are two obvious positions for additional promoters in the DNA sequence. The termination codon of doxG is approximately 250 bp upstream of the initiation codon of doxH. doxI and doxJ are similarly separated (Fig. 3) . No fluorescent products were produced from DBT in P. putida KT2440 when doxI was mutated, although colored products were observed. Expression of the entire 9.8-kb fragment in E. coli results in the production of an orange, nonfluorescent product like that seen in P. putida when doxI is mutated, indicating that the pathway in E. coli stops before doxl. We know the pathway is functional in E. coli through doxG since the E. coli doxG mutants also accumulate the brown product (coumarin) (data not shown). The fact that the entire 9.8-kb fragment causes accumulation of an orange product in E. coli, and not the brown coumarin, indicates that doxH or doxJ must be active. There are numerous sequence motifs 5' to doxH and doxJ that strongly resemble Pseudomonas promoter consensus sequences. These findings are consistent with the idea that doxI and either doxH or doxJ might be under the control of additional Pselidomonas promoters which are not recognized by E. coli, suggesting that they may constitute a separate operon.
Conclusions. The DOX genes encode a complete upper naphthalene catabolic pathway that is responsible for the conversion of naphthalene to salicylate. The DOX sequence represents the first complete DNA sequence for an upper naphthalene catabolic pathway. Recently, C18 was reported to be incapable of removing organically bound sulfur from DBT (45) . This observation and our findings that the DBT-metabolizing genes from C18 encode an upper naphthalene catabolic pathway lead us to conclude that the ability of C18 to metabolize DBT is limited to oxidation of the aromatic ring in a manner similar to that described for the upper naphthalene catabolic pathway, NAH.
